Vaping and dabbing are the most prevalent routes of use among persons aged 18 to 24 years
Compared with those with all-cause hospital-based care and the general population, risk increased for those with cannabis use-based care
Review shows benefits for social responsiveness, disruptive behavior, and anxiety
Additionally, specific symptom improvement seen
Commercial administrative claims data show slight increase in annual prevalence from 2015 to 2020
Findings persist across various periods
Risk for death higher for individuals with hospital-based care for alcohol, stimulant, opioids versus cannabis use disorder
Schizophrenia-associated increase seen from prelegalization to legalization of nonmedical cannabis periods
Anterior insula, medial prefrontal cortex, and dorsolateral prefrontal cortex associated with history of heavy use
Findings seen for younger adults across cannabis use disorder severity levels